Author:
ten Ham Renske M.T.,Nievaart Julianne C.,Hoekman Jarno,Cooper Rachel S.,Frederix Geert W.J.,Leufkens Hubert G.M.,Klungel Olaf H.,Ovelgönne Hans,Hoefnagel Marcel H.N.,Turner Marc L.,Mountford Joanne C.
Subject
Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy
Reference53 articles.
1. Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial;Burt;JAMA - J Am Med Assoc,2019
2. The European Parliament and the Council of the European Union. Regulation (EC) No 1394/2007 of the European Parliament and of the Council. Off J Eur Union. 2007;324((EC)1394/2007):121–38.
3. Regulatory framework for advanced therapy medicinal products in Europe and United States;Iglesias-López;Front Pharmacol,2019
4. Turning Regenerative Medicine Breakthrough Ideas and Innovations into Commercial Products;Bayon;Tissue Eng - Part B Rev,2015
5. Funding breakthrough therapies : a systematic review and recommendation;Hanna;Health Policy (New York).,2018
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献